U.S. Insurance Stock News

Tempus AI (NasdaqGS:TEM) announced a collaboration with Median Technologies to integrate eyonis LCS, an FDA cleared AI software for lung cancer screening, into its Tempus Pixel platform. The integration is aimed at supporting lung cancer detection and risk stratification as part of Tempus AI's broader precision medicine and diagnostics offering. For you as an investor, this move sits at the intersection of AI, oncology, and clinical workflows, an area where Tempus AI is already active...

If you are wondering whether Quanta Services at around US$525 a share still offers value, you are not alone. This article is designed to help you assess that question clearly. The stock has recorded returns of 2.8% over the last 7 days, 12.5% over the last 30 days, 19.4% year to date and 82.8% over the past year, with a very large 5 year return that is well over 5x the starting point. This naturally raises questions about what is already priced in. Recent headlines around Quanta Services...

Waystar Holding (NasdaqGS:WAY) has rapidly integrated Iodine Software following its acquisition, completing key revenue cycle and clinical intelligence alignment ahead of schedule. The combined platform now reaches a larger hospital client base and is being recognized nationally for its AI driven revenue cycle automation. Waystar was recently named an Inc. Best in Business honoree for AI Implementation, highlighting its role in healthcare revenue cycle automation. Waystar's recent moves...

Federated Hermes (FHI) has drawn fresh attention after recent trading left the shares with a reported intrinsic discount of about 13%, prompting investors to reassess the asset manager’s valuation and long term return profile. See our latest analysis for Federated Hermes. Recent trading has been choppy, with the 1 day share price return of Federated Hermes at a 1% decline. However, the 90 day share price return of 14.24% and the 1 year total shareholder return of 46.58% point to building...

Cognex recently reported fourth-quarter 2025 sales of US$252.34 million and full-year sales of US$994.36 million, alongside higher net income and earnings per share, while completing a US$500 million share repurchase program and declaring a quarterly dividend of US$0.085 per share. On top of these capital returns, the Board refreshed its membership by appointing automation and enterprise sales veterans Dr. Sami Atiya and Chris Donato, changes that could influence how Cognex pursues AI-driven...

Coherent (COHR) is back in focus after a surge in bullish option activity and higher implied volatility ahead of its May 6 earnings report, alongside fresh industry awards for its optical networking products. See our latest analysis for Coherent. After a strong run that includes a 30 day share price return of 15.14% and a 90 day share price return of 53.88%, Coherent’s recent 1 year total shareholder return of 148.04% and 3 year total shareholder return of over 4x suggest momentum has been...

In the fourth quarter of 2025, Oasis Management disclosed buying 833,500 Vail Resorts shares, lifting its stake by about US$122.66 million despite season-to-date skier visits falling 20% and related lift, ski school, and dining revenues also declining due to below-average snowfall. This sizable purchase by a professional investor, even after a weak ski season, highlights differing views on Vail Resorts’ longer-term business resilience and earnings power. We’ll now examine how Oasis...

Interparfums, the fragrance maker behind brands such as Kate Spade and Abercrombie & Fitch, recently attracted attention after analysts revised earnings estimates higher for the quarter ended December 2025, even as they anticipated earnings would decline year over year on higher revenue. This shift in expectations, alongside the company’s track record of 14.1% annual revenue growth over the past three years and strong returns on invested capital, has reinforced confidence in its ability to...

Why Savara’s recent FDA progress is back in focus Savara (SVRA) is back on investor radars after resubmitting its biologics license application, completing a tech transfer to Fujifilm, and aligning key analytical protocols with the FDA. With an FDA filing decision expected in the near term and management expressing strong confidence in the updated package, the upcoming Guggenheim Securities Emerging Outlook, Biotech Summit presentation on February 11 is drawing extra attention from...

If you are wondering whether LeMaitre Vascular at around US$89.25 is priced fairly or not, this article will walk through what the current valuation actually implies for you as a shareholder or potential investor. The stock shows a mix of recent returns, with gains of 1.4% over the last 7 days, 1.1% over 30 days and 11.3% year to date, but a 10.6% decline over 1 year, alongside longer term returns of 85.6% over 3 years and 98.2% over 5 years. Recent news coverage around LeMaitre Vascular has...

In February 2026, Plug Power Inc. shareholders approved a charter amendment to increase authorised common stock from 1.50 billion to 3.00 billion shares, effective February 12 following filing in Delaware. This expanded share capacity gives Plug Power more room to raise equity capital, refinance obligations, and fund operations during a leadership transition from CEO Andy Marsh to Jose Luis Crespo. Next, we will examine how this substantial expansion of authorised shares could influence Plug...

3M stock at a glance 3M (MMM) has been drawing attention after recent share price moves, with the stock closing at $167.62 and short term returns mixed across the past week, month, and past 3 months. See our latest analysis for 3M. Recent trading has been choppy, with a 1 day share price return of a 2.44% decline and a modest 3.58% share price return year to date. The 1 year total shareholder return of 14.58% and 3 year total shareholder return of just over 2x suggest longer term holders have...

Earlier this month, Wix.com Ltd. and Intuit Inc. expanded their partnership, allowing millions of Wix users to integrate Intuit’s QuickBooks Online AI-powered financial tools directly with Wix’s website and ecommerce platform. This collaboration deepens Intuit’s ecosystem reach by embedding its financial management and AI capabilities inside Wix’s online business workflows, potentially increasing the appeal and stickiness of Intuit’s small-business offerings. Next, we’ll examine how...

If you are wondering whether Danaher at around US$206 per share still offers good value, you are not alone. The answer depends on how you look at its underlying business and valuation. The stock has recently been under pressure, with a 6.1% decline over the last week, a 12.6% decline over the last month and a 10.4% decline year to date, although the 1 year return sits at 1.5%. These moves sit against a backdrop of ongoing interest in large, diversified life sciences and diagnostics...

In recent days, AECOM reported first-quarter 2026 results showing lower sales and net income year over year, completed a multi-year US$3.14 billion share repurchase program, secured new design work on Sydney Metro West in joint venture with WSP, and entered a new global mobility and infrastructure planning partnership announced by TomTom. These developments highlight AECOM’s focus on higher-value consulting and digital capabilities, while continued buybacks and raised 2026 earnings guidance...

Chewy (NYSE:CHWY) is pushing further into pet healthcare, insurance, and advertising as new business lines. The company is leaning on its Autoship subscription program to deepen customer loyalty and support these services. This combination of higher margin offerings and recurring revenue is reshaping how Chewy positions itself in the pet market. Chewy enters this shift with its shares at $23.8, after a 37.5% decline over the past year and a 78.3% decline over the past five years. The stock...

Caterpillar has completed its acquisition of mining software company RPMGlobal, expanding its mining technology and planning tools. The deal adds advanced data, scheduling and site management capabilities to Caterpillar's existing mining equipment and digital offerings. The move supports Caterpillar's push to offer more integrated, software driven solutions to mining customers. Caterpillar, traded as NYSE:CAT, now has RPMGlobal's mining software portfolio alongside its existing hardware and...

If you are wondering whether SentinelOne's current share price reflects its true worth, this article will walk through what the numbers are really saying about the stock. After its last close at US$13.40, SentinelOne's returns sit at a 2.4% decline over 7 days, a 3.6% decline over 30 days, an 8.5% decline year to date, and a 45.0% decline over the past year, with a 12.5% decline over 3 years. Recent coverage of SentinelOne has focused on its position in cybersecurity and how investor...

In February 2026, PHINIA Inc. reported that fourth-quarter 2025 sales rose to US$889 million with net income of US$45 million, while full-year 2025 sales reached US$3.48 billion and net income climbed to US$130 million, alongside higher diluted earnings per share from continuing operations for both periods versus the prior year. The company also issued 2026 guidance calling for net sales of US$3.52 billion to US$3.72 billion and higher projected net earnings, reinforcing investor attention...

Why Federal Realty Investment Trust (FRT) Is In Focus After Its Latest Earnings Federal Realty Investment Trust (FRT) has drawn fresh attention after reporting fourth quarter and full year 2025 results, issuing 2026 earnings guidance, and affirming regular common and preferred dividends on the same day. See our latest analysis for Federal Realty Investment Trust. The earnings beat, fresh 2026 guidance and confirmation of both common and preferred dividends come as Federal Realty Investment...

Regulators have lifted the clinical hold on Intellia Therapeutics' MAGNITUDE-2 study, allowing the gene editing trial to resume. The decision follows updates to safety protocols after rare adverse events were evaluated. The cleared pathway enables expanded enrollment for MAGNITUDE-2 and continued work on Intellia's in vivo gene editing program. For you as an investor looking at Intellia Therapeutics (NasdaqGM:NTLA), this regulatory step comes as the stock trades at $12.22. The share price...

Construction Partners, Inc. recently reported first-quarter 2026 results showing sales of US$809.47 million and net income of US$17.21 million, and it raised full-year fiscal 2026 revenue and net income guidance while also completing a US$22.94 million share repurchase program announced in April 2024. Alongside these financial updates, the company’s participation at the Barclays 43rd Annual Industrial Select Conference in Miami in February 2026 gave management an additional platform to...

Wondering whether Deere at around US$600 a share still offers fair value, or if the price has already run too far ahead of the fundamentals? This article is built to help you answer that question calmly and clearly. The stock last closed at US$600.84, with returns of 1.3% over 7 days, 16.8% over 30 days, 28.7% year to date, 21.4% over 1 year, 46.7% over 3 years, and 90.1% over 5 years. This naturally raises questions about what is already priced in and how much risk is now on the...

EPAM Systems (NYSE:EPAM) has launched Empathy Lab, an AI native agency, in North America. The move follows the earlier roll out of Empathy Lab in Europe and is aimed at helping brands modernize marketing and technology using AI. EPAM has appointed Ben Hall as Head of Empathy Lab for North America to lead the expansion. EPAM Systems is rolling out this new AI focused offering at a time when its share price is around $162.2 and recent returns have been weak. The stock shows a 15.3% decline...